Stockreport

Skye Bioscience Announces Participation in February Conferences

Skye Bioscience, Inc.  (SKYE) 
PDF SAN DIEGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therape [Read more]